ED
37
-6
CL
58
2
TMO
60
4
DD
45
-7
L
71
2
COP
47
3
ETR
47
-2
PCG
74
2
ZTS
21
2
FITB
75
2
AIG
77
2
ZION
71
2
MA
55
4
PLD
30
2
APH
56
7
KLAC
72
2
ESS
40
-5
ADP
54
-4
F
59
3
PBI
68
2
ED
37
-6
CL
58
2
TMO
60
4
DD
45
-7
L
71
2
COP
47
3
ETR
47
-2
PCG
74
2
ZTS
21
2
FITB
75
2
AIG
77
2
ZION
71
2
MA
55
4
PLD
30
2
APH
56
7
KLAC
72
2
ESS
40
-5
ADP
54
-4
F
59
3
PBI
68
2
Financhill
Back

Columbia Research Enhanced Value ETF Vs. Madrigal Pharmaceuticals, Inc. Industry Stock Comparison

Buy
56

REVS
Columbia Research Enhanced Value ETF

Last Price:
$28.17
Seasonality Move:
1.74%
Buy
67

MDGL
Madrigal Pharmaceuticals, Inc.

Last Price:
$591.74
Seasonality Move:
15.11%
Buy
56
Columbia Research Enhanced Value ETF (REVS) is a Buy

Is Columbia Research Enhanced Value ETF a Buy, Sell or Hold?

  • The current Columbia Research Enhanced Value ETF [REVS] share price is $28.30. The Score for REVS is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • REVS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
Madrigal Pharmaceuticals, Inc. (MDGL) is a Buy

Is Madrigal Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Madrigal Pharmaceuticals, Inc. [MDGL] share price is $591.02. The Score for MDGL is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • MDGL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

REVS Stock Price Chart

What is Columbia Research Enhanced Value ETF's stock price today?

  • The Columbia Research Enhanced Value ETF share price today is $28.30
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REVS is experiencing slight selling pressure.

MDGL Stock Price Chart

What is Madrigal Pharmaceuticals, Inc.'s stock price today?

  • The Madrigal Pharmaceuticals, Inc. share price today is $591.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.

REVS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.34 Buy
Relative Strength Index (14 RSI): 46.58 Sell
Chaikin Money Flow: -4892 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.86 - 28.96) Sell
Bollinger Bands (100): (27.28 - 28.44) Buy

MDGL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 12.54 Buy
Relative Strength Index (14 RSI): 63.09 Buy
Chaikin Money Flow: 850060 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (548.18 - 585.88) Buy
Bollinger Bands (100): (384.94 - 533.12) Buy

REVS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.85 Sell
20-day SMA: 28.61 Sell
50-day SMA: 28.21 Buy
200-day SMA: 26.54 Buy
8-day EMA: 15.03 Buy
20-day EMA: 7.37 Buy
50-day EMA: 3.21 Buy
200-day EMA: 0.84 Buy

MDGL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 561.5 Buy
20-day SMA: 571.82 Buy
50-day SMA: 508.82 Buy
200-day SMA: 382.95 Buy
8-day EMA: 564.29 Buy
20-day EMA: 558.29 Buy
50-day EMA: 520.52 Buy
200-day EMA: 411.49 Buy

Columbia Research Enhanced Value ETF Earnings Growth & REVS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Madrigal Pharmaceuticals, Inc. Earnings Growth & MDGL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $3.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $12.33 per share, and an increase next year of $13.64 per share.

Columbia Research Enhanced Value ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Madrigal Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):